# FDA Inspection 1008518 - Lato Drug Co. Inc. dba Post Haste Pharmacy - April 11, 2017

Source: https://www.keypedia.com/records/fda_inspections/lato-drug-co-inc-dba-post-haste-pharmacy/e5d787cf-cb9f-48ef-a4b0-067ffd19a738
Source feed: FDA_Inspections

> FDA Inspection 1008518 for Lato Drug Co. Inc. dba Post Haste Pharmacy on April 11, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008518
- Company Name: Lato Drug Co. Inc. dba Post Haste Pharmacy
- Inspection Date: 2017-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 917948 - 2015-02-20](https://www.keypedia.com/records/fda_inspections/lato-drug-co-inc-dba-post-haste-pharmacy/8b55658f-7bd7-47af-b012-e5edf4b652dd)

Company: https://www.keypedia.com/companies/lato-drug-co-inc-dba-post-haste-pharmacy/e01b5750-1975-4f86-a7e9-b2e6875c3f90

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c